XVARY Composite Score
31
/ 100
Weak
Combines growth, value, risk, and momentum factors into a single institutional-grade score.
Start here if you're new
What it is
Safeguard is a public shell of private-company stakes across software, fintech, and healthcare.
How it gets paid
Last year Safeguard made n/a in revenue.
What just happened
The clean takeaway is simple: quarterly EPS landed at -$0.32 in Q4 2024, the weakest quarter of the year.
At a Glance
C++ balance sheet — some cracks in the foundation
10/100 earnings predictability — expect surprises
53.4% return on capital — a money-printing machine
-$0.62 fy2024 eps est
1.1 beta
XVARY composite: 31/100 — weak
What They Do
Safeguard is a public shell of private-company stakes across software, fintech, and healthcare.
The moat is mostly patience, not scale. Safeguard backs niche technology, financial services, and healthcare companies, with capital commitments of up to $25 million in selected business services, so one good exit can matter a lot. If you own this, you are betting on deal selection, not a customer base that cannot leave.
How They Make Money
n/a
annual revenue
The Products That Matter
Manages and exits legacy holdings
Portfolio management
no operating segment disclosed here
This is effectively the whole business. Your return depends on what management can sell, what cash remains, and whether the process stops the current -36.03% return on equity from getting worse.
liquidation case
Key Numbers
$0.73
share price
You are looking at a sub-$1 stock, which usually means the market already assumes very little margin for error.
-$0.62
2024 eps
EPS → profit per share → so what: Safeguard lost 62 cents for every share in 2024.
53.4%
return on capital
Return on capital → profit from invested money → so what: the reported figure is high, but with sparse data you should treat it carefully.
10/100
price stability
Price stability → how calm the stock trades → so what: this name is built for swings, not sleep.
Financial Health
C++
Strength
- balance sheet grade C++ — below average — limited financial resources
- risk rank 5 — safer than 5% of stocks
- price stability 10 / 100
C++ — below average. watch for debt servicing and cash burn.
Total Return vs. Market
source: institutional data · return history unavailable
What Just Happened
missed estimates
The clean takeaway is simple: quarterly EPS landed at -$0.32 in Q4 2024, the weakest quarter of the year.
Quarterly EPS moved from -$0.13 to -$0.10 to -$0.07, then fell to -$0.32 in Q4 2024. Full-year EPS was -$0.62 in 2024 versus -$0.61 in 2023, so the business did not turn the corner.
$0M
revenue
-$0.32
eps
n/a
n/a
the number that mattered
Q4 EPS of -$0.32 matters most because it accounted for more than half of the full-year -$0.62 loss.
source: quarterly EPS history and Yahoo Finance consensus data, 2024
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. Plain English, no spam.
Weekly updates
Earnings alerts
Plain English
No spam
What Could Go Wrong
The top risk is liquidation execution on a shrinking asset base — you are relying on management to sell what remains before more value disappears.
Med
Asset sales can lock in bad outcomes
A company in wind-down has fewer ways to fix mistakes. With return on equity at -36.03%, you already have proof that shareholder capital has been moving the wrong way.
If exits come at weak prices, the remaining equity base can shrink further and the stock has little operating strength to offset it.
Med
There is no operating engine underneath this
Return on assets sits at -11.74%, and this snapshot shows no revenue segment to underwrite. In plain English: you do not have a normal business compounding in the background while you wait.
That means 100% of the thesis rests on residual asset value, balance-sheet preservation, and management disclosure quality.
Med
Thin information can amplify volatility
Price stability is 10 / 100 and earnings predictability is 10 / 100. Those are bad numbers separately. Together they tell you the stock can react hard to very little information.
You are exposed not just to weak fundamentals, but to the gap between sparse updates and market expectations.
With no operating revenue shown here, -36.03% return on equity, and 10 / 100 price stability, you are underwriting liquidation outcomes, not business execution.
Source: institutional data · regulatory filings · risk analysis
Pay Attention To
Catalyst
March 13, 2026 update
This is the next scheduled checkpoint. You want hard evidence on asset sales, cash, and whether the wind-down is getting cleaner or messier.
Metric
Return on equity versus zero
-36.03% is the number to beat. Until it gets back toward positive territory, the liquidation story is still leaking value.
Risk
Disclosure quality
Thin data is part of the risk here. If updates stay vague, the market has to guess at residual value, and guessing is rarely kind to small shells.
Signal
Price stability at 10 / 100
That score says this is not a sleepy asset stub. It can move sharply on limited news because there is so little else for the market to anchor to.
Analyst Rankings
earnings predictability
10 / 100
In human-speak, analysts do not have a stable earnings pattern to lean on here.
beta
1.1
Beta measures how a stock tends to move with the market. Here it says SFES is roughly market-like on paper, but the real risk is company-specific.
price stability
10 / 100
This is the opposite of stable. The tape can move before the fundamentals tell you much.
Source: institutional data
Institutional Activity
institutional ownership data for SFES is being compiled.
Source: institutional data
Price Targets
3-5 year target range
$1
Current price
Target midpoint · from current
Want the deeper analysis?
The full deep dive: DCF model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
See plans from $5/moThe Deep Dive